Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Biography
I am a medical oncologist who specializes in the care of patients with gastrointestinal malignancies. My research interests focus on the investigation of new therapies for these diseases, particularly cancers of the liver and biliary system.
Fingerprint
Dive into the research topics where Celina Ang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Vithayathil, M., D’Alessio, A., Fulgenzi, C. A. M., Nishida, N., Schönlein, M., von Felden, J., Schulze, K., Wege, H., Saeed, A., Wietharn, B., Hildebrand, H., Wu, L., Ang, C., Marron, T. U., Weinmann, A., Galle, P. R., Bettinger, D., Bengsch, B., Vogel, A., Balcar, L., & 15 others, Aug 2023, In: Hepatology International. 17, 4, p. 904-914 11 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma
Macfie, R., Berger, Y., Liu, H., Li, T., Imtiaz, S., Ang, C., Sarpel, U., Hiotis, S., Labow, D., Golas, B. & Cohen, N. A., Aug 2023, In: Annals of Surgical Oncology. 30, 8, p. 5027-5034 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
Wu, Y. L., van Hyfte, G., Özbek, U., Reincke, M., Gampa, A., Mohamed, Y. I., Nishida, N., Wietharn, B., Amara, S., Lee, P. C., Scheiner, B., Balcar, L., Pinter, M., Vogel, A., Weinmann, A., Saeed, A., Pillai, A., Rimassa, L., Naqash, A. R., Muzaffar, M., & 5 others, 2023, In: Frontiers in Oncology. 13, 1128569.Research output: Contribution to journal › Article › peer-review
Open Access -
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study
Talbot, T., D'Alessio, A., Pinter, M., Balcar, L., Scheiner, B., Marron, T. U., Jun, T., Dharmapuri, S., Ang, C., Saeed, A., Hildebrand, H., Muzaffar, M., Fulgenzi, C. A. M., Amara, S., Naqash, A. R., Gampa, A., Pillai, A., Wang, Y., Khan, U., Lee, P. C., & 16 others, Mar 2023, In: Liver International. 43, 3, p. 695-707 13 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
Vithayathil, M., D'Alessio, A., Fulgenzi, C. A. M., Nishida, N., Schönlein, M., von Felden, J., Schulze, K., Wege, H., Saeed, A., Wietharn, B., Hildebrand, H., Wu, L., Ang, C., Marron, T. U., Weinmann, A., Galle, P. R., Bettinger, D., Bengsch, B., Vogel, A., Balcar, L., & 15 others, Nov 2022, In: Liver International. 42, 11, p. 2538-2547 10 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations
Press/Media
-
New Liver Cancer Study Findings Reported from Icahn School of Medicine at Mount Sinai (Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus ...)
Celina Ang & Linda Wu
23/12/22
1 item of Media coverage
Press/Media
-
Immunotherapy Continues to Shape Evolving Treatment Armamentarium of GI Cancers
Deirdre Cohen, Peter Kozuch & Celina Ang
30/08/22
1 item of Media coverage
Press/Media
-
A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer; PROTACT
Celina Ang & Christopher DiMaio
2/10/18
1 item of Media coverage
Press/Media